Fagron NV (EBR:FAGR)
Belgium · Delayed Price · Currency is EUR 22.25
-0.25 (-1.11%)
Aug 31, 2026, 5:39 PM CET
Fagron NV Market Cap
Fagron NV has a market cap or net worth of €1.65 billion as of August 31, 2026. Its market cap has increased by 8.82% in one year.
Market Cap
1.65B
Enterprise Value
2.16B
Revenue
1.03B
Ranking
n/a
PE Ratio
18.00
Stock Price
€22.25
ChartMarket Cap Chart
Since October 15, 2007, Fagron NV's market cap has increased from 312.17M to 1.65B, an increase of 428.65%. That is a compound annual growth rate of 9.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 1.65B | 5.78% |
| Dec 31, 2025 | 1.56B | 27.67% |
| Dec 31, 2024 | 1.22B | 0.73% |
| Dec 29, 2023 | 1.21B | 25.41% |
| Dec 30, 2022 | 967.24M | -10.30% |
| Dec 31, 2021 | 1.08B | -21.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 55.98B |
| UCB SA | 41.28B |
| Financière de Tubize | 8.30B |
| Ion Beam Applications | 489.85M |
| Onward Medical | 171.74M |
| Nyxoah | 144.10M |
| Hyloris Pharmaceuticals | 123.76M |
| Sequana Medical NV | 43.56M |